TGFBR2 and fatty liver disease: Moreover, in a NASH mouse model, hepatocyte-specific TGFB receptor type II (Tgfbr2) deficiency reduced hepatic steatosis, inflammation, hepatic stellate cell activation, and collagen deposition17.